Prot# WA17043/U2644g: A Randomized, Multifactorial, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of Rituximab (Mabthera®/Rituxan®) In Combination with Methotrexate in Patients with Active Rheumatoid Arthritis

Project: Research project

Project Details

StatusFinished
Effective start/end date7/11/036/1/07

Funding

  • Genentech, Inc. (WA17043/U2644g)